Dr. Natasha Hunter is a translational breast cancer researcher and clinical oncologist at UW/FHCC. She has research interests in circulating tumor DNA to guide treatment and monitor for tumor presence/response, and in immunologic approaches to detection and treatment of micrometastatic disease and prevention of cancer recurrence. She joined the CVI in 2026 and is now serving as the Director of Clinical Trials and principal investigator for multiple clinical trials.